Sophie Nock
Research Associate
My profile
Biography
Biographical information
Research outputs
-
Journal articles
Nock, S., Karim, E., Unsworth, A.J. (2023) 'Pim kinases: important regulators of cardiovascular disease.' International Journal of Molecular Sciences, 24(14) pp. 11582-11582.
Kriek, N., Nock, S., Sage, T., Khalifa, B., Bye, A.P., Mitchell, J., Thomson, S., McLaughlin, M., Jones, S., Gibbins, J., Unsworth, A. (2022) 'Cucurbitacins elicit anti-platelet activity via perturbation of the actin cytoskeleton and integrin function.' Thrombosis and Haemostasis,
Holbrook, L.M., Keeton, S.J., Sasikumar, P., Nock, S., Gelzinis, J., Brunt, E., Ryan, S., Pantos, M.M., Verbetsky, C.A., Gibbins, J.M., Kennedy, D.R. (2021) 'Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.' British Journal of Pharmacology, 178(3) pp. 550-563.
Nicolson, P.L.R., Nock, S.H., Hinds, J., Garcia-Quintanilla, L., Smith, C.W., Campos, J., Brill, A., Pike, J.A., Khan, A.O., Poulter, N.S., Kavanagh, D.M., Watson, S., Watson, C.N., Clifford, H., Huissoon, A.P., Pollitt, A.Y., Eble, J.A., Pratt, G., Watson, S.P., Hughes, C.E. (2021) 'Low-dose Btk inhibitors selectively block platelet activation by CLEC-2.' Haematologica, 106(1) pp. 208-219.
Nicolson, P.L.R., Hughes, C.E., Watson, S., Nock, S.H., Hardy, A.T., Watson, C.N., Montague, S.J., Clifford, H., Huissoon, A.P., Malcor, J.D., Thomas, M.R., Pollitt, A.Y., Tomlinson, M.G., Pratt, G., Watson, S.P. (2018) 'Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI.' Haematologica, 103(12) pp. 2097-2108.
Bye, A.P., Unsworth, A.J., Desborough, M.J., Hildyard, C.A.T., Appleby, N., Bruce, D., Kriek, N., Nock, S.H., Sage, T., Hughes, C.E., Gibbins, J.M. (2017) 'Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib..' Blood Advances, 1(26) pp. 2610-2623.